ETOPOSIDE INJECTION
As listed in the register: ETOPOSIDE INJECTION, USP
20 mg · solution
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Etoposide
- Made by
- Strides Pharma Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (ETOPOSIDE). It describes the substance, not this exact product.
Etoposide has been shown to cause metaphase arrest in chick fibroblasts.
Its main effect, however, appears to be at the G 2 portion of the cell cycle in mammalian cells.
In children, approximately 55% of the dose is excreted in the urine as etoposide in 24 hours.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-23
Safety of the active substance
From the US prescribing label for the same active substance (ETOPOSIDE). It describes the substance, not this exact product.
Warnings Etoposide should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
- Etoposide is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Strides Pharma Canada Inc |
|---|---|
| Active substance | Etoposide |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 20 mg |
| Form | solution |
| Classification | L01CB01 · Cancer treatments and immune-system medicines |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Dormant |
| Marketed | No — authorised but not currently marketed, according to the register |
| Name in the register | ETOPOSIDE INJECTION, USP |
| DIN | 02422530 |
| DPD drug code | 90722 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution3 products
20 mg3
20 mg · 3 companies
- Hikma Canada Limited
- Strides Pharma Canada Inc · this page
- Teva Canada Limited
- liquid1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.